Published Date:2023-11-09 Original Link:https://www.onenessbio.com/en/news_detail249_1.htm No 2 Date of announcement 2023/11/09 Time of announcement 20:54:04 Subject FESPIXON, the new drug in treatment of diabetic foot ulcers has been approved as Class 1.1 natural new drug by National Medical Products Administration (NMPA) in China. To which item it meets paragraph 10 Date of events 2023/11/09 Statement 1.Product:FESPIXON,...Read More

Published Date:2023-11-09 Original Link:https://www.onenessbio.com/en/news_detail248_1.htm No 1 Date of announcement 2023/11/09 Time of announcement  16:52:05 Subject The Company’s 2023Q3 consolidated financial statements have been approved by the Board of Directors. To which item it meets paragraph 31 Date of events 2023/11/09 Statement 1. Date of the board of directors submitted or approved:2023/11/09 2. Date of the...Read More